A prospective outcomes and cost-effective analysis of surgery compared to stereotactic body radiation therapy for stage I non-small cell lung cancer.
Saved in:
| Title: | A prospective outcomes and cost-effective analysis of surgery compared to stereotactic body radiation therapy for stage I non-small cell lung cancer. |
|---|---|
| Authors: | Kennedy A; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA. Andrew.Kennedy@SarahCannon.com.; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA. Andrew.Kennedy@SarahCannon.com.; Sarah Cannon Cancer Network, 1100 Charlotte Avenue Suite 825, Nashville, TN, 37203, USA. Andrew.Kennedy@SarahCannon.com., Egloff SAA; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA.; HCA Healthcare Research Institute (HRI), HCA Healthcare, Nashville, USA., Martin C; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA.; HCA Healthcare Research Institute (HRI), HCA Healthcare, Nashville, USA.; Genospace, Boston, USA., Gilmore D; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA., Garwood S; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA.; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA.; HCA Healthcare Research Institute (HRI), HCA Healthcare, Nashville, USA., Baxter T; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA., Spigel D; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA.; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA., Johnson M; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA., Randolph Ii D; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA., Chollet-Lipscomb C; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA., Cuttino L; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA., Osborne E; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA., Marks J; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA., Doshi P; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA.; HCA Healthcare Research Institute (HRI), HCA Healthcare, Nashville, USA.; Genospace, Boston, USA., Mattlin M; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA.; HCA Healthcare Research Institute (HRI), HCA Healthcare, Nashville, USA.; Genospace, Boston, USA., Geer R; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA.; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA., Kurbegov D; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA.; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA.; HCA Healthcare Research Institute (HRI), HCA Healthcare, Nashville, USA., Burris Iii H; Sarah Cannon Cancer Network (SCCN), HCA Healthcare, Tennessee, USA.; Sarah Cannon Research Institute (SCRI), HCA Healthcare, Nashville, USA. |
| Source: | Radiation oncology (London, England) [Radiat Oncol] 2025 Aug 05; Vol. 20 (1), pp. 123. Date of Electronic Publication: 2025 Aug 05. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
